China: A recent case-control study published in the Journal of Inflammation Research has shed light on a potential ...

Netherlands: A recent study published in the European Journal of Trauma and Emergency Surgery highlights the potential of ...

In the assessment of 12-month price targets, analysts unveil insights for Insmed, presenting an average target of $99.0, a ...

Ensoma, a genomic medicines company advancing the future of medicine through one-time, in vivo therapies, today announced U.S ...